This morning, Johnson & Johnson shared its second-quarter performance.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.
“The resilience of our diversified business has enabled us to continue delivering value to our stakeholders, even in the face of the COVID-19 global pandemic,” says Joseph Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This sustainability, coupled with Johnson & Johnson’s rich history of being at the forefront of scientific innovation, public health and global community impact, reinforces our long-term business outlook, and motivates our colleagues and partners to responsibly develop and provide a safe, effective and affordable vaccine to people around the world as soon as possible.”
For more details about the company’s 2020 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.
Johnson & Johnson’s 2020 2nd-Quarter Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
